Leerink analyst Jonathan Chang raised the firm’s price target on Replimune (REPL) to $21 from $18 to reflect an increased probability of ...

Stephens Inc. AR reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 14,439 shares ...

The leveraged finance and private equity communities came together on 29 January 2025 for the inaugural Leveraged Finance Fights ...

H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Replimune Group (NASDAQ:REPL), currently trading at $13.79 with a market cap of $1.06 billion, to $22.00, up from the previous ...

I tried the new AI scan for skin cancer with results in 30 seconds — and it's better than a dermatologist - The Skin ...

The patient reported that the lesion had become slightly raised with irregular borders ... There were no personal or family histories of malignant melanoma. Skin examination showed an 8 mm × ...

A benefit for South Lake Tahoe local Jennifer Milligin, who is recovering from Ocular Melanoma (eye cancer), will be held at ...

Dick Vitale called Clemson basketball vs Duke after a three-year absence, during which he battled cancer. Here's how Clemson ...

Vitale made his long-awaited return after having fought melanoma, lymphoma ... but Vitale's presence raised the stakes even higher. "The fact that he's at our first game back (in) two years ...

Before vocal cord cancer, Vitale battled melanoma, lymphoma, and lymph node cancer ... With the assistance of the Dick Vitale ...

"The £1.4M raised by LFFM London will have a transformative impact on our mission," said Stephanie Kauffman, president of the Melanoma Research Alliance. "This generous support allows us to ...